Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.
Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.
Cronos Group (NASDAQ: CRON) reported Q1 2026 net revenue of $45.2 million, up 40% year-over-year, with gross profit of $19.2 million and net income of $15.7 million. Adjusted EBITDA rose to $5.1 million. Cash and cash equivalents totaled $821.9 million.
The Board authorized a new $50 million share repurchase program commencing May 14, 2026. Cronos highlighted record revenue in Israel and other international markets, leading Canadian vape and edibles share, and extended the outside date to close its planned CanAdelaar acquisition to September 9, 2026.
Cronos (NASDAQ: CRON) expanded distribution of Spinach STIX®, its first cylindrical-style pre-roll, to eight Canadian provinces on May 6, 2026. The launch targets growing consumer demand for cylindrical pre-rolls, which represented $17 million in March 2026 retail sales and the pre-roll category that accounts for 33%+ of national retail dollar sales.
Spinach STIX® ships in 10x0.4g formats across three strains with advertised THC levels of 24%–26%+ and is positioned as a portable, even-burning pre-roll option.
Cronos Group (NASDAQ: CRON; TSX: CRON) will hold its 2026 Annual Meeting of Shareholders in a virtual-only format on Thursday, June 18, 2026 at 11:00 a.m. ET. Registered shareholders and duly appointed proxyholders may participate, ask questions, and vote online.
The company’s proxy statement and participation instructions are available on the investor relations website. A replay will be posted in the investor relations events section about 24 hours after the meeting.
Cronos Group (NASDAQ: CRON) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Senior management will discuss the Company’s financial results and answer investor questions after prepared remarks.
Participants should register online and are encouraged to dial in 15 minutes early; the webcast will be archived for replay on the company website.
Cronos Group (NASDAQ: CRON) announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 38th Annual ROTH Conference on Monday, March 23, 2026 at 11:30 AM PDT.
A live webcast will be available via the company’s Investors site at https://ir.thecronosgroup.com/events-presentations, allowing investors to watch the presentation in real time.
Cronos Group (NASDAQ: CRON) reported record net revenue of $44.5M in Q4 2025 and $146.6M for FY 2025, up 47% and 25% year-over-year respectively. Adjusted EBITDA improved to $10.1M for the year. The company holds approximately $832M in cash and short-term investments and announced a €57.5M (~$67M) agreement to acquire CanAdelaar, subject to Netherlands regulatory clearances expected in H1 2026.
Cronos (NASDAQ: CRON) launched Spinach PUFFERZ™, a 1g all‑in‑one vape infused with liquid diamonds and delivering 98.1% THC. The palm‑style device features a squishy exterior, dual ceramic coil, boost button and battery meter. Three flavors debut now in Alberta, British Columbia and Ontario; national availability by April 2026.
The product targets modern cannabis consumers seeking design, flavor and convenience under the Spinach brand.
Cronos (NASDAQ: CRON; TSX: CRON) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET.
Senior management will discuss financial results and take investor questions after prepared remarks. Registration and webcast access are available via the company’s investor website, and the webcast will be archived for replay.
Cronos Group (NASDAQ: CRON) launched its premium Lord Jones cannabis brand in Israel on February 2, 2026, introducing five indoor-grown flower strains to the Israeli medical market.
The rollout emphasizes small-batch indoor cultivation, cold-cure processing, hand trimming and glass jar packaging, and will expand with special editions and limited-run products.
Cronos (NASDAQ: CRON) announced on December 9, 2025 that a wholly‑owned subsidiary signed a definitive agreement to acquire CanAdelaar B.V., the largest company in the Netherlands’ adult‑use cannabis pilot (Wietexperiment).
Up‑front consideration is €57.5 million (US$67.0 million), roughly 1.4x LTM revenue and 2.4x LTM EBITDA, with an additional cash earnout equal to 0.5x normalized EBITDA in 2026 and 2027. Cronos said the deal will deliver a #1 market share in the Netherlands and support its borderless product strategy using existing genetics, R&D, and product development investments.